Smac modulates chemosensitivity in head and neck cancer cells through the mitochondrial apoptotic pathway

Quanhong Sun1, Xingnan Zheng, Lin Zhang

  • 1University of Pittsburgh Cancer Institute, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA.

Abstract

Insights

Second mitochondria-derived activator of caspase (Smac) plays a key role in head and neck cancer therapy. Smac mimetics enhance chemotherapy effectiveness by promoting apoptosis and overcoming resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Inhibitors of apoptosis proteins (IAP) overexpression drives therapeutic resistance in cancers.
  • Second mitochondria-derived activator of caspase (Smac) antagonizes IAPs, promoting apoptosis.
  • Smac mimetics are a novel class of anticancer agents targeting IAPs.

Purpose of the Study:

  • To investigate the role of Smac in mediating chemosensitization in head and neck squamous cell carcinoma (HNSCC).
  • To elucidate the mechanisms underlying Smac and Smac mimetic-induced chemosensitization.
  • To evaluate the therapeutic potential of Smac mimetics in HNSCC models.

Main Methods:

  • Assessed effects of SMAC knockdown, overexpression, and a small molecule Smac mimetic on HNSCC chemosensitivity.
  • Analyzed growth suppression, mitochondrial apoptotic pathway activation, caspase activation, and IAP protein levels.
  • Compared therapeutic responses in HNSCC xenograft models with varying Smac levels.

Main Results:

  • Smac mediates apoptosis induced by various therapeutic agents via the mitochondrial pathway.
  • SMAC knockdown impaired caspase activation and cytochrome c release.
  • Smac mimetic sensitized HNSCC cells to gemcitabine, restoring sensitivity in SMAC knockdown cells.
  • Smac levels influenced HNSCC response to gemcitabine in vivo.

Conclusions:

  • Smac critically mediates therapeutic responses in HNSCC cells.
  • Combining Smac mimetics with chemotherapy presents a strong therapeutic strategy for HNSCC.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...